Overview

The GMO Equity Dislocation Investment Fund seeks high total return. It aims to own attractively valued equities while correspondingly shorting equities where we believe that valuations are reflective of implausible growth expectations. Currently, the Fund is long global Value, short global Growth, to take advantage of the exceptionally wide valuation spread between Value and Growth.

The eligible universe for both the long and short side spans the market capitalization spectrum and includes both developed and emerging markets. Utilizing GMO’s proprietary Price to Fair Value model to actively select the cheapest and most expensive stocks, the portfolio is diversified across sectors, countries, and regions and is intended to be approximately beta neutral.

Facts

Doc Table
Fund Inception Date May 10, 2021
Fund Total Assets as of 30/11/2024 $1.4bn USD

EUR Class L

Inception Date June 23, 2022
SEDOL BF19925
ISIN IE00BF199251
NAV as of 06/12/2024 19.07

Performance

Quarter-End as of September 30, 2024(EUR, %) | Equity Dislocation Investment Fund EUR L

Table Caption
QTD YTD 1-Year ITD
Equity Dislocation Investment Fund -3.47 0.90 -0.69 0.64
Barclays Benchmark Overnight EUR Cash Index 0.97 3.02 4.06 2.95
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Quarter-End as of September 30, 2024(EUR, %) | Equity Dislocation Investment Fund EUR L

Table Caption
QTD YTD 1-Year ITD
Equity Dislocation Investment Fund -3.37 1.21 -0.27 1.06
Barclays Benchmark Overnight EUR Cash Index 0.97 3.02 4.06 2.95
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Month-End as of November 30, 2024(EUR, %) | Equity Dislocation Investment Fund EUR L

Table Caption
MTD QTD YTD 1-Year ITD
Equity Dislocation Investment Fund -3.99 -5.03 -4.18 -2.58 -1.51
Barclays Benchmark Overnight EUR Cash Index 0.26 0.56 3.60 3.93 2.98
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Month-End as of November 30, 2024(EUR, %) | Equity Dislocation Investment Fund EUR L

Table Caption
MTD QTD YTD 1-Year ITD
Equity Dislocation Investment Fund -3.95 -4.96 -3.81 -2.17 -1.09
Barclays Benchmark Overnight EUR Cash Index 0.26 0.56 3.60 3.93 2.98
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Year Ending December 31 (EUR, %) | Equity Dislocation Investment Fund EUR L

Calendar
Equity Dislocation Investment Fund Barclays Benchmark Overnight EUR Cash Index
2023 2.08 3.37
2022 -1.50 0.31
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Year Ending December 31 (EUR, %) | Equity Dislocation Investment Fund EUR L

Calendar
Equity Dislocation Investment Fund Barclays Benchmark Overnight EUR Cash Index
2023 2.51 3.37
2022 -1.27 0.31
  • Equity Dislocation Investment Fund
  • Barclays Benchmark Overnight EUR Cash Index

Inception Date: June 23, 2022

Returns shown for periods greater than one year are on an annualized basis.

Gross of fees, expenses and transaction costs, if any. If these fees, expenses and costs were included, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Documents

Literature

Prospectus Download
Prospectus - Supplement Download
Prospectus – Singapore Wrapper Download
KIIDs Download
PRIIPs Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Investor Information

Annual Report Download
Semiannual Report Download
NAVs and Distributions Download
Fair Value Hierarchy - As of 30/09/23 Download
Fair Value Hierarchy - As of 31/03/24 Download
Download All Download

Risks

Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Short Investment Exposure Risk: A Fund will incur a loss as a result of a short sale if the price of the security, currency or other instrument increases between the date of the short sale and the date on which the Fund replaces the borrowed security, currency or other instrument. Conversely, the Fund will realize a gain if the price of the security, currency or other instrument declines between those dates. The amount of any gain will be decreased, and the amount of any loss increased, by the amount of the premium, dividends or interest the Fund may be required to pay in connection with a short sale. Short selling exposes a Fund to unlimited risk with respect to that security, currency or other instrument due to the lack of an upper limit on the price to which an investment can rise. (3) Non-U.S. Investment Risk: The market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets) are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets.For a more complete discussion of these risks and others, please consult the Fund's Prospectus.

Disclosures

The making available of any document on this website does not constitute a promotion, offer or sale of any securities, financial instruments, or other financial products to the public in or into any jurisdiction where such promotion, offer or sale is prohibited or to any person or class of person to whom such securities or financial instruments may not be lawfully promoted, offered or sold. You should not rely on any document on this website in making any decision to engage in investment activity without seeking further information from GMO to enable GMO to determine whether you may be eligible to receive such further information or purchase or subscribe for any securities or other financial instruments.

This product is based overseas and is not subject to the UK sustainable investment labelling and disclosure requirements. Please refer to the UK Financial Conduct Authority webpage for more information: https://www.fca.org.uk/consumers/sustainable-investment-labels-greenwashing